/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
The Company, headquartered in Cranford, New Jersey, is a biopharmaceutical company focused on developing and commercializing innovative targeted oncology therapies. The Company s strategy centers on achieving a market leading position by advancing innovative therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclus…
$1.14
+$0.12 (+11.76%)
EOD Sep 18, 2026
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$46M
▼ -17.1% YoY
Op. Margin
—
ROIC
-80.63%
▲ +29.6pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (FY)
-$5M
▼ -4446.6% YoY
Net Debt
-$10M
Net Cash Position
Cash & Equiv.
$17M
Continue Research
SourceComputed from the 10-Q filed 14 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 15 Aug 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Sep. Sector medians are approximate S&P 500 benchmarks and update periodically.